Feature | Cath Lab | September 14, 2016

VIVA Announces Late-Breaking Clinical Trial Presentations

VIVA 2016, late breaking trials, cath lab

Vascular Interventional Advances (VIVA) 2016 released its list late-breaking research presentations in vascular interventions. All trials represent data never before presented and are of global significance to physicians and others interested in the rapid advancement of therapies for vascular diseases. The meeting is Sept. 18-22, in Las Vegas, Nev.

Presentations Monday, Sept. 19 

8:31 AM — MOBILE Clinical Trial: MarrOwStim PAD Kit for the Treatment of Critical Limb Ischemia (CLI) in Subjects with Severe Peripheral Arterial Disease (PAD) — Michael P. Murphy, M.D., FACS

8:43 AM — Safety and Performance of the Shockwave Lithoplasty System in Treating Calcified Peripheral Vascular Lesions: Six-Month Results from the Two-phase DISRUPT PAD Study — Thomas Zeller, M.D.

8:55 AM — Results from the IN.PACT SFA Randomized Trial — Prakash Krishnan, M.D.

9:07 AM — VIRTUS US Iliofemoral Stenting IDE Trial  — Stephen Black, M.D.

9:19 AM — Drug-Coated Balloon Treatment for Patients With Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort — Michael R. Jaff, D.O.   

 

Presentations Tuesday, Sept. 20 

8:10 AM — Endovascular Repair in Acute, Complicated Type B Aortic Dissection: 3-Year Results from the Valiant US-IDE Study — Ali Azizzadeh, M.D.  

8:22 AM — Fast-Track Endovascular Aortic Repair: Final Results from the Prospective LIFE Registry — Zvonimir Krajcer, M.D.      

8:34 AM — Arteriovenous Fistula (AVF) Post-Creation Interventions: a Comparison Between Traditional Surgical AVF Creation and a New Endovascular Approach — Charmaine Lok, M.D., FRCPC        

8:46 AM — MAJESTIC 2 Year Results Plus Sub-group Analysis —Stefan Müller-Hülsbeck, M.D.

8:59 AM — 2 Year Results of Paclitaxel Coated Balloons for Long Femoro-popliteal Artery Disease: Evidence from the SFA-Long Study — Antonio Micari, M.D., Ph.D.    

 

Presentations Wednesday, Sept. 21

9:10 AM — ESPRIT I Trial: Three-Year Results of The Evaluation of The ESPRIT Bioresorbable Vascular Scaffold (ESPRIT BVS) in The Treatment of Patients with Occlusive Vascular Disease of the Superficial Femoral (SFA) or Common or External Iliac Arteries — Richard Rapoza, M.D.  

9:22 AM — 12 Month Results from the DANCE Trial Atherectomy Cohort — Chris Owens, M.D.      

9:34 AM — Use of an Expanded Polytetrafluoroethylene (ePTFE) Balloon-Expandable Covered Stent for Obstructive Lesions in the Iliac Artery: Nine-Month Results from the Prospective, Multicenter BOLSTER Trial 
— John Laird, M.D.

9:44 AM — Carotid Stent Fractures are not associated with Restenosis, Stroke, Myocardial Infarction or Death: Results from the ACT 1 Multicenter Randomized Trial — Ido Weinberg, M.D.   

9:54 AM — Novel Nitinol Stent for Long Lesions in the Superficial Femoral Artery and Proximal Popliteal Artery: 24 Month Results from the TIGRIS Randomized Trial  — John Laird, M.D.   

10:04 AM — PRISM Indigo Aspiration System as a Potential Frontline Tool for Vacuum-assisted Aspiration Thrombectomy in the Periphery  — Richard Saxon, M.D. 

 

For more information: vivaphysicians.org/annual-conference/viva-16/

Related Content

Complete Revascularization Superior to Culprit Lesion-only Intervention
News | Cath Lab | September 10, 2019
An international randomized trial has shown that complete revascularization reduces major cardiovascular events...
The cath lab staff UH Portage Medical Center.

The cath lab staff UH Portage Medical Center.

Feature | Cath Lab | September 09, 2019 | Anjan Gupta, M.D., FACC, FSCAI
Primary percutaneous coronary intervention (PCI) is the preferred treatment for acute...
FDA Grants Shockwave Medical Breakthrough Status for Coronary Intravascular Lithotripsy
News | Cath Lab | September 03, 2019
Shockwave Medical Inc. has received Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA)...
Compound Could Help Improve Heart Attack Recovery
News | Cath Lab | August 27, 2019
Imagine there were a drug that you could take soon after a heart attack that could reduce damage by protecting healthy...
New Alliance Announced Between Transcatheter Cardiovascular Therapeutics and VEITHsymposium
News | Cath Lab | June 20, 2019
VEITHsymposium and the Cardiovascular Research Foundation (CRF) announced an alliance between Transcatheter...
Novel Index Accurately Predicts PCI Success Post-Procedure Compared to Established Measurement Metrics
News | Cath Lab | June 19, 2019
Results from a comprehensive analysis demonstrate the effectiveness of measuring a non-hyperemic pressure ratio (NHPR...
Philips Healthcare, Volcano IVUS showing an implanted stent. IVUS might offer an alternative to contrast angiography in patients with acute kidney disease (AKD).
News | Cath Lab | June 14, 2019
June 14, 2019 – A late-breaking study examined the effects of intravascular ultrasound (IVUS) guided drug-eluting ste
Videos | Cath Lab | May 20, 2019
This is a walk through of the primary structural heart hybrid cath lab at...
Overlay Init